Short sellers are piling into SECZ at the worst possible moment for borrowing. Securitize Corp. reports earnings tomorrow. The lending market is nearly locked up.
Short interest jumped 20.7% in a single day on August 11. That puts total short shares at 4.31 million — up 22.4% on the week.
Meanwhile, availability has collapsed to just 7.9%. For every 100 shares already borrowed, only about 8 remain available to lend. That is firmly in "very tight" territory. The tightest reading over the past 52 weeks was 5.8%.
Cost to borrow has reflected the strain. It peaked at 15.46% earlier this week before settling back to 11.63% on August 11. That is still up 57.6% over the past month — roughly double where it stood in early July, when CTB was below 5%.
The availability chart tells the real story. On July 6, availability stood at 286%. By July 31 it had dropped to 5.8%. It has bounced around that floor since, never recovering above 22%.
That means this isn't a one-day dislocation. Short sellers have been systematically building positions while the lending pool shrinks. The mismatch between growing demand and shrinking supply is what drove the CTB spike.
Three firms initiated coverage of SECZ in the past month. Citizens (Devin Ryan) set a $15 price target on August 11 — more than double the current $7.39. Rosenblatt (Chris Brendler) targets $14. Citigroup (Peter Christiansen) is more cautious at $10.
All three rate it Buy or Market Outperform. The consensus is constructive. The short sellers disagree.
SECZ reports before the open on August 13. That is the event around which everything in this snapshot is organized.
Short interest at 4.31 million shares. Availability at 7.9%. CTB up 58% in a month. Analysts clustered with targets 35–103% above the current price.
What to watch: whether the print resolves the bull-bear standoff, and how quickly availability moves if short sellers need to cover.
Data summary
See the live data behind this article on ORTEX.
Open SECZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
